Total Payments
$3,069
2024 Payments
$820.05
Companies
19
Transactions
167
Medicare Patients
2,325
Medicare Billing
$123,868
Payment Breakdown by Category
Food & Beverage$2,989 (97.4%)
Education$79.99 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,989 | 166 | 97.4% |
| Education | $79.99 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $601.58 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $561.20 | 28 | $0 (2024) |
| PFIZER INC. | $312.05 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $303.93 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $252.01 | 16 | $0 (2024) |
| Amgen Inc. | $219.59 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $199.58 | 9 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $139.72 | 8 | $0 (2024) |
| Boston Scientific Corporation | $84.39 | 4 | $0 (2024) |
| Novo Nordisk Inc | $83.35 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $820.05 | 44 | Novartis Pharmaceuticals Corporation ($176.83) |
| 2023 | $987.96 | 52 | Novartis Pharmaceuticals Corporation ($225.36) |
| 2022 | $889.33 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($301.28) |
| 2021 | $371.28 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($126.42) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.40 | General |
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.21 | General |
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Obesity | ||||||
| 06/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Cardiology | ||||||
| 06/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 05/30/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.38 | General |
| 05/28/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiology | ||||||
| 04/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/18/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 745 | 809 | $210,157 | $39,420 |
| 2022 | 6 | 654 | 731 | $157,209 | $36,011 |
| 2021 | 6 | 485 | 522 | $108,779 | $28,478 |
| 2020 | 4 | 441 | 475 | $91,421 | $19,959 |
Total Patients
2,325
Total Services
2,537
Medicare Billing
$123,868
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 421 | 484 | $179,080 | $34,370 | 19.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 42 | 42 | $10,626 | $2,332 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 169 | 170 | $12,410 | $1,313 | 10.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 93 | 93 | $7,161 | $1,258 | 17.6% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2023 | 20 | 20 | $880.00 | $147.24 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 371 | 440 | $122,548 | $30,937 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $8,570 | $2,123 | 24.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 150 | 155 | $17,249 | $1,144 | 6.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2022 | 76 | 76 | $4,916 | $1,023 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 18 | $3,114 | $616.57 | 19.8% |
| 93040 | Electrocardiogram (ecg) 1 to 3 leads with review by physician | Office | 2022 | 18 | 21 | $812.00 | $167.88 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 276 | 310 | $78,740 | $22,855 | 29.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $8,624 | $2,319 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 34 | $5,882 | $1,948 | 33.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 111 | 112 | $13,328 | $851.64 | 6.4% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2021 | 27 | 27 | $1,593 | $389.88 | 24.5% |
| 93040 | Tracing of electrical activity of heart using 1-3 leads with interpretation and report | Office | 2021 | 15 | 17 | $612.00 | $114.10 | 18.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 220 | 252 | $64,008 | $16,498 | 25.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 171 | 173 | $20,587 | $1,741 | 8.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 34 | $5,882 | $1,480 | 25.2% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Office | 2020 | 16 | 16 | $944.00 | $240.02 | 25.4% |
About Julia Stephenson, PA-C
Julia Stephenson, PA-C is a Physician Assistant healthcare provider based in Evans, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2018. The National Provider Identifier (NPI) number assigned to this provider is 1548759285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Julia Stephenson, PA-C has received a total of $3,069 in payments from pharmaceutical and medical device companies, with $820.05 received in 2024. These payments were reported across 167 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,989).
As a Medicare-enrolled provider, Stephenson has provided services to 2,325 Medicare beneficiaries, totaling 2,537 services with total Medicare billing of $123,868. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Cardiovascular Disease
- Location Evans, GA
- Active Since 05/08/2018
- Last Updated 08/31/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1548759285
Products in Payments
- JARDIANCE (Drug) $561.20
- LEQVIO (Drug) $409.70
- VERQUVO (Drug) $303.93
- ELIQUIS (Drug) $287.40
- XARELTO (Drug) $252.01
- Repatha (Biological) $219.59
- ENTRESTO (Drug) $191.88
- FARXIGA (Drug) $119.59
- BRILINTA (Drug) $79.99
- MULTAQ (Drug) $78.95
- MITRACLIP (Device) $58.64
- Vascepa (Drug) $50.93
- Inpefa (Drug) $45.73
- Wegovy (Drug) $42.96
- WATCHMAN FLX (Device) $38.23
- VYNDAMAX (Drug) $37.99
- Arcalyst (Drug) $36.07
- WATCHMAN Access System (Device) $25.84
- FUROSCIX (Drug) $24.12
- Ozempic (Drug) $23.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Evans
Savanna Perry, Pa-C, PA-C
Physician Assistant — Payments: $7,760
Physician Assistant $7,760
Kristin House, Pa, PA
Physician Assistant — Payments: $6,814
Physician Assistant $6,814
Mr. Joseph Crosby, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $5,190
Physician Assistant $5,190
Danielle Elbert, Pa-C, PA-C
Physician Assistant — Payments: $5,161
Physician Assistant $5,161
Mrs. Kacee Morris, Pa-C, PA-C
Physician Assistant — Payments: $4,925
Physician Assistant $4,925
Jennifer Mumford, Pa-C, PA-C
Physician Assistant — Payments: $3,695
Physician Assistant $3,695